{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:27:33Z","timestamp":1761395253324,"version":"3.37.3"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001322","name":"South African MRC Flagship","doi-asserted-by":"publisher","award":["MRC-RFA-UFSP-01-2013"],"award-info":[{"award-number":["MRC-RFA-UFSP-01-2013"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,1,7]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The emergence of resistance to the artemisinins which are the current mainstays for antimalarial chemotheraphy has created an environment where the development of new drugs acting in a mechanistally discrete manner is a priority.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The goal of this work was to synthesize ane evaluate bis-thiosemicarbazones as potential antimalarial agents. &lt;\/P&gt;&lt;P&gt; Methods: Fifteen compounds were generated using two condensation protocols and evaluated in vitro against the NF54 (CQ sensitive) strain of Plasmodium falciparum. A preliminary assessment of the potential for human toxicity was conducted in vitro against the MRC5 human lung fibroblast line.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The activity of the bis-thiosemicarbazones was highly dependent on the nature of the arene at the core of the structure. The inclusion of a non-coordinating benzene core resulted in inactive compounds, while the inclusion of a pyridyl core resulted in compounds of moderate or potent antimalarial activity (4 compounds showing IC50 &lt; 250 nM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Bis-thiosemicarbazones containing a central pyridyl core display potent antimalarial activity in vitro. Sequestration and activation of ferric iron appears to play a significant role in this activity. Ongoing studies are aimed at further development of this series as potential antimalarials.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406414666180525132204","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T03:58:35Z","timestamp":1527479915000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Evaluation of Metal Co-ordinating Bis-Thiosemicarbazones as Potential Anti-malarial Agents"],"prefix":"10.2174","volume":"15","author":[{"given":"Fady N.","family":"Akladios","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, Charles Sturt University, Orange, NSW 2800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Andrew","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Charles Sturt University, Orange, NSW 2800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha J.","family":"Boog","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Charles Sturt University, Orange, NSW 2800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"de Kock","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, University of Cape Town, Groote Schuur Hospital, Observatory 7925, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Haynes","sequence":"additional","affiliation":[{"name":"Centre for Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2531, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Parkinson","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Charles Sturt University, Orange, NSW 2800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"author":"","unstructured":", . World Malaria Report, 2016. World Health Organization: Geneva; Available at: www.who.int, , ,","key":"ref=1"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","volume":"19","author":"Miller L.H.","year":"2013","unstructured":"Miller LH, Ackerman HC, Su XZ, Wellems TE. Nat Med, Malaria biology and disease pathogenesis: insights for new treatments.,, 2013, 19,, 156-167,","journal-title":"Nat Med"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"Arley F.","year":"2014","unstructured":"Arley F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Khim S, Duru V, Boichier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Menard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Menard D. Nature, A molecular marker of artemisinin-resistant malaria.,, 2014, 505,, 50-55,","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1038\/ncomms9614","volume":"6","author":"St Laurent B.","year":"2015","unstructured":"St Laurent B, Miller B, Burton TA, Amaratunga C, Men S, Sovannaroth S, Fay MP, Miotto O, Gwadz RW, Anderson JM, Fairhurst RM. Nat Commun, Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.,, 2015, 6,, 8614-,","journal-title":"Nat Commun"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMp1108322","volume":"365","author":"Dondorp A.M.","year":"2011","unstructured":"Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Bremen JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV. N Engl J Med, The threat of artemisinin-resistant malaria.,, 2011, 365,, 1073-1075,","journal-title":"N Engl J Med"},{"key":"ref=6","first-page":"1","volume":"3","author":"Phillips M.A.","year":"2017","unstructured":"Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat. Rev. Disease Primers., , (article number 17050)., 2017","journal-title":"Malaria Nat Rev Disease Primers"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"Gamo F.J.","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF. Nature, Thousands of chemical starting points for antimalarial lead identification.,, 2010, 465,, 305-310,","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","volume":"16","author":"Phyo A.","year":"2016","unstructured":"Phyo A, Jittamala P, Nosten FH, Pukrittayakamee S, Imwong M, White NJ, Duparc S, Macintyre F, Baker M, M\u00f6hrle JJ. Lancet Infect Dis, Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.,, 2016, 16,, 61-69,","journal-title":"Lancet Infect Dis"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa1602250","volume":"375","author":"White N.J.","year":"2016","unstructured":"White NJ, Duong TT, Uthaisin C, Nosten F, Phyo AP, Hanboonkunupakarn B, Pukrittayakamee S, Jittamala P, Chuthasmit K, Cheung MS, Feng Y, Li R. N Engl J Med, Magnusson, Marc Sultan, M.; Wieser, D.; Xun, X.; Zhao, R.; Diagana, T.T.; Pertel, P.; Leong, F.J. Antimalarial activity of KAF156 in falciparum and vivax malaria.,, 2016, 375,, 1152-1160,","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","volume":"371","author":"White N.J.","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Phyo AP, Rueangweerayut R, Nosten FH, Jittamala P, Jeeyapant A, Jain JP, Lef\u00e8vre G, Li R, Magnusson B, Diagana TT, Leong FJ. N Engl J Med, Spiroindolone KAE609 for falciparum and vivax malaria.,, 2014, 371,, 403-410,","journal-title":"N Engl J Med"},{"key":"ref=11","first-page":"48","volume":"1","author":"Gu H.M.","year":"1980","unstructured":"Gu HM, Lu BF, Qu ZX. Acta Pharmacol Sinica, Antimalarial activity of 25 derivatives of artemisinin against chloroquine-resistant Plasmodium berghei.,, 1980, 1,, 48-50,","journal-title":"Acta Pharmacol Sinica"},{"key":"ref=12","first-page":"523","volume":"56","author":"Wozencraft A.O.","year":"1985","unstructured":"Wozencraft AO, Croft SL, Sayers G. Immunology, Impairment of macrophage functions after ingestion of Plasmodium falciparum -infected erythrocytes or isolated malarial pigment.,, 1985, 56,, 523-531,","journal-title":"Immunology"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(83)92603-X","volume":"i","author":"Clark I.A.","year":"1983","unstructured":"Clark IA, Cowden WB, Butcher GA. Lancet, Free oxygen radicals in malaria.,, 1983, i,, 234-,","journal-title":"Lancet"},{"key":"ref=14","first-page":"1745","volume":"38","author":"Bachur N.R.","year":"1978","unstructured":"Bachur NR, Gordon SL. Cancer Res, A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Gee, M.V.,, 1978, 38,, 1745-1750,","journal-title":"Cancer Res"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/cmdc.201200383","volume":"7","author":"Haynes R.K.","year":"2012","unstructured":"Haynes RK, Cheu K-W, Chan H-W, Wong H-N, Li K-Y, Tang MM-K, Chen MJ, Guo Z-F, Guo Z-H, Sinniah K, Witte AB, Coghi P, Monti D. ChemMedChem, Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model \u2013 a unifying proposal for drug action.,, 2012, 7,, 2204-2226,","journal-title":"ChemMedChem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-2952(88)90173-6","volume":"37","author":"Zhang Y.","year":"1988","unstructured":"Zhang Y, Konig I, Schirmer RH. Biochem Pharmacol, Glutathione reductase deficient erythrocytes as host cells for malaria parasites.,, 1988, 37,, 861-865,","journal-title":"Biochem Pharmacol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0006-2952(88)90172-4","volume":"37","author":"Zhang Y.A.","year":"1988","unstructured":"Zhang YA, Hempelmann E, Schirmer RH. Biochem Pharmacol, Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro.,, 1988, 37,, 855-860,","journal-title":"Biochem Pharmacol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/jm00402a001","volume":"31","author":"Vennerstrom J.L.","year":"1988","unstructured":"Vennerstrom JL, Eaton JW. J Med Chem, Oxidants, oxidant drugs and malaria.,, 1988, 31,, 1269-1277,","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/bi00549a600","volume":"19","author":"Chou A.C.","year":"1980","unstructured":"Chou AC, Chevli R, Fitch CD. Biochemistry, Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites.,, 1980, 19,, 1543-1549,","journal-title":"Biochemistry"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/355167a0","volume":"355","author":"Slater A.F.G.","year":"1992","unstructured":"Slater AFG, Cerami A. Nature, Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.,, 1992, 355,, 167-169,","journal-title":"Nature"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(97)00510-8","volume":"55","author":"Dorn A.","year":"1998","unstructured":"Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG. Biochem Pharmacol, An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials.,, 1998, 55,, 727-736,","journal-title":"Biochem Pharmacol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00034983.1996.11813065","volume":"90","author":"Meshnick S.R.","year":"1996","unstructured":"Meshnick SR. Ann Trop Med Parasitol, Is haemozoin a target for antimalarial drugs?,, 1996, 90,, 367-372,","journal-title":"Ann Trop Med Parasitol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0163-7258(98)00037-0","volume":"81","author":"Mabeza G.F.","year":"1999","unstructured":"Mabeza GF, Loyevsky M, Gordeuk VR, Weiss G. Pharmacol Therap, Iron chelation therapy for malaria: a review.,, 1999, 81,, 53-75,","journal-title":"Pharmacol Therap"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.168.1.375","volume":"168","author":"Hershko C.","year":"1988","unstructured":"Hershko C, Peto TE. J Exp Med, Deferoxamine inhibition of malaria is independent of host iron status.,, 1988, 168,, 375-387,","journal-title":"J Exp Med"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1182\/blood.V79.2.308.308","volume":"79","author":"Gordeuk V.R.","year":"1992","unstructured":"Gordeuk VR, Thuma PE, Brittenham GM, Zulu S, Simwanza G, Mahangu A, Flesch G, Parry D. Blood, Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia.,, 1992, 79,, 308-312,","journal-title":"Blood"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood.V85.11.3297.bloodjournal85113297","volume":"85","author":"Gordeuk V.R.","year":"1995","unstructured":"Gordeuk VR, Thuma PE, McLaren CE, Biemba G, Zulu S, Poltera AA, Askin JE, Brittenham GM. Blood, Transferrin saturation and recovery from coma in cerebral malaria.,, 1995, 85,, 3297-3301,","journal-title":"Blood"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jac\/dkl117","volume":"57","author":"Pradines B.","year":"2006","unstructured":"Pradines B, Tall A, Ramiandrosa F, Spiegel A, Sokhna C, Fusai T, Mosnier J, Daries W, Trape JF, Kunesch G, Parzy D, Rogier CJ. J Antimicrob Chemother, In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.,, 2006, 57,, 1093-1099,","journal-title":"J Antimicrob Chemother"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1357-2725(03)00248-6","volume":"36","author":"Walcourt A.","year":"2004","unstructured":"Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR, Richardson DR. Int J Biochem Cell Biol, Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.,, 2004, 36,, 401-407,","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bmcl.2005.09.058","volume":"16","author":"Melnyk P.","year":"2006","unstructured":"Melnyk P, Leroux V, Sergheraert C, Grellier P. Bioorg Med Chem Lett, Design, synthesis and in vitro antimalarial activity of an acylhydrazone library.,, 2006, 16,, 31-35,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0022-2143(96)90148-1","volume":"127","author":"Tsafack A.","year":"1996","unstructured":"Tsafack A, Loyevsky M, Ponka P, Ioav Cabantchik Z. J Lab Clin Med, Mode of action of iron(III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.,, 1996, 127,, 574-582,","journal-title":"J Lab Clin Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e37171","DOI":"10.1371\/journal.pone.0037171","volume":"7","author":"Ferrer P.","year":"2012","unstructured":"Ferrer P, Tripathi AK, Clark MA, Hand CC, Reinhoff HY, Sullivan DJ. PLoS One, Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single dose cure in a murine malaria model.,, 2012, 7,, e37171-,10.1371\/journal.pone.0037171","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.04642-14","volume":"59","author":"Ferrer P.","year":"2015","unstructured":"Ferrer P, Vega-Rodriguez J, Tripathi AK, Jacobs-Lorena M, Sullivan DJ. Antimicrob Agents Chemother, Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.,, 2015, 59,, 1418-1426,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00775-016-1390-7","volume":"21","author":"Akladios F.N.","year":"2016","unstructured":"Akladios FN, Andrew SD, Parkinson CJ. J Biol Inorg Chem, Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.,, 2016, 21,, 931-944,","journal-title":"J Biol Inorg Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1039\/B416296J","author":"Pedrido R.","year":"2005","unstructured":"Pedrido R, Bermejo MR, Romero MJ, V\u00e1zquez M, Gonz\u00e1lez-Noya AM, Maneiro M, Rodr\u00edguez MJ, Fern\u00e1ndez MI. Dalton Transactions, Synthesis and X-ray characterisation of metal complexes with the pentadentate thiosemicarbazone ligand bis (4-N-methylthiosemi-carbazone)-2,6-diacetylpyridine. The first pentacoordinate lead(II) complex with a pentagonal geometry.,, 2005, 21,, 572-579,","journal-title":"Dalton Transactions"},{"key":"ref=35","first-page":"130","volume":"66","author":"Kinfe H.H.","year":"2013","unstructured":"Kinfe HH, Belay YH. S Afr J Chem, Synthesis and biological evaluation of novel thiosemicarbazone-triazole hybrid compounds as antimalarial agents.,, 2013, 66,, 130-135,","journal-title":"S Afr J Chem"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ardp.201000201","volume":"344","author":"Kulandaivelu U.","year":"2011","unstructured":"Kulandaivelu U, Padmini VG, Suneetha K, Shireesha B, Vidyasagar JV, Rao TR, Jayaveera KN, Basu A, Jayaprakash V. Archiv der Pharmazie, Synthesis, antimicrobial and anticancer activity of new thiosemicarbazone derivatives.,, 2011, 344,, 84-90,","journal-title":"Archiv der Pharmazie"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2180-14-167","volume":"14","author":"Asahi H.","year":"2014","unstructured":"Asahi H, Tolba MEM, Tanabe M, Sugano S, Abe K, Kawamoto F. BMC Microbiol, Perturbation of copper homeostasis is instrumental in early developmental arrest of intraerythrocytic Plasmodium falciparum.,, 2014, 14,, 167-177,","journal-title":"BMC Microbiol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1517\/14728222.9.5.995","volume":"9","author":"Lai H.","year":"2005","unstructured":"Lai H, Sasaki T, Singh NP. Expert Opin Ther Targets, Targeted treatment of cancer with artemisinin aand artemisinin-tagged iron carrying compounds.,, 2005, 9,, 995-1007,","journal-title":"Expert Opin Ther Targets"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/ja109665t","volume":"133","author":"Miller M.J.","year":"2011","unstructured":"Miller MJ, Walz AJ, Zhu H, Wu C, Moraski G, Mollman U, Tristani EM, Crumbliss AL, Ferdig MT, Checkley L, Edwards RL, Boshoff HI. J Am Chem Soc, Design, synthesis and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria.,, 2011, 133,, 2076-2079,","journal-title":"J Am Chem Soc"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"Trager W.","year":"1976","unstructured":"Trager W, Jensen JB. Science, Human malaria parasite in continuous culture.,, 1976, 193,, 673-675,","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","volume":"48","author":"Makler M.T.","year":"1993","unstructured":"Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ. Am J Trop Med Hyg, Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity.,, 1993, 48,, 739-741,","journal-title":"Am J Trop Med Hyg"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/162467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T13:38:06Z","timestamp":1571405886000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/162467\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666180525132204","relation":{},"ISSN":["1573-4064"],"issn-type":[{"type":"print","value":"1573-4064"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}